Nanopore sensing enables precise detection of peptide modifications, suggesting improved biomarker identification.
Effective and precise detection of peptides and their post-translational modifications (PTMs) is crucial for biomedical research but remains technically challenging. Here, we present a nanopore sensing strategy that enables label-free analysis of negatively charged peptides. By introducing arginine residues into the nanopore and using amino-cyclodextrin as a molecular adaptor, the system enables unambiguous discrimination of short negatively charged homopeptides differing by only a single residue. Building on this capability, the platform further demonstrates high sensitivity for detecting representative PTMs, including acetylation, lactylation, and phosphorylation, introduced on a negatively charged peptide scaffold. Notably, the system could also analyze fragments generated by proteolytic digestion of full-length proteins, underscoring its potential for accurate protein identification. This work offers an accessible and reliable strategy to characterize peptide variants with single-amino acid differences and PTMs, which may facilitate future applications in peptide biomarker detection and protein sequence analysis.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: